The Exchange has sought clarification from Gland Pharma Limited with respect to recent news item captioned Pharma stocks slump as Trump shoots letters to 17 global drug majors seeking lower prices. The response from the Company is awaited.
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.3 pts less than Nifty Smallcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The National Stock Exchange has asked Gland Pharma to clarify a recent news article in which pharmaceutical stocks fell after reports that US President Trump sent letters to 17 global drug majors seeking lower drug prices. The exchange wants the company to share its views or confirm/deny any impact. Gland Pharma's response is still awaited and has not yet been submitted to the exchange.
This is a routine clarification request and does not indicate any wrongdoing or specific action against the company. Shareholders should wait for the company's official response, which could provide clarity on whether Gland Pharma is among the 17 drug majors contacted or whether its US business may be affected.